先天性心疾患治療市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00017800
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Congenital Heart Disease Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

市場紹介 先天性心疾患は、先天性心欠損 (CHD) としても知られ、出生時に奇形または未発達の心臓が存在する病気です。症状はまったくない場合から生命を脅かす場合までさまざまです。症状が現れる場合には、体重増加の低下、呼吸の速さ、チアノーゼ、倦怠感などが含まれる場合があります。心臓の欠陥によって生じる可能性のある合併症には、心不全が含まれます。 市場のダイナミクス 世界の先天性心疾患治療市場の成長を促進する要因は、先天性心疾患の有病率の上昇と低侵襲手術の採用の増加です。さらに、多くの支配的な市場プレーヤー、カテーテル治療の需要の高まり、先天性心疾患治療における心臓バイオマーカーの応用も、予測期間中の世界の先天性心疾患市場の成長を促進する重要な要因と考えられています。ただし、先天性心疾患の治療費が高額であるため、市場の成長が妨げられます。 市場範囲 「2031年までの先天性心疾患治療市場分析」は、世界市場動向分析に特に焦点を当てた、医薬品業界の専門的で詳細な調査です。このレポートは、種類とエンドユーザーによる詳細な市場セグメンテーションを含む、先天性心疾患治療市場の概要を提供することを目的としています。先天性心疾患治療市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、先天性心疾患治療市場の主要企業の市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。 市場分割 先天性心疾患治療市場は、種類とエンドユーザーに基づいて分割されています。先天性心疾患の治療市場は、タイプに基づいて薬物療法と外科療法に分けられます。エンドユーザーに基づいて、先天性心疾患治療市場は病院、診療所、診断センターに分類できます。

Congenital Heart Disease Treatment Market: Strategic Insights

Congenital Heart Disease Treatment Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Novartis AG
  • Merck and Co Inc
  • Pfizer Inc
  • Amgen Inc
  • Abbott Laboratories
  • Sanofi S A
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • AstraZeneca plc

Regional Overview

Regional And Country Scope
  • 北米(米国,カナダ,メキシコ)
  • ヨーロッパ(英国,ドイツ,フランス,ロシア,イタリア,その他のヨーロッパ)
  • アジア太平洋(中国,インド,日本,オーストラリア,その他のアジア太平洋)
  • 南米および中米(ブラジル,アルゼンチン,その他の中南米)
  • 中東およびアフリカ(南アフリカ,サウジアラビア,UAE,その他の中東およびアフリカ)

Market Segmentation

Segment 1タイプ(薬物療法,外科療法)
    Segment2エンドユーザー(病院,診療所,診断センター)
      Segment3地理
      • 北アメリカ
      • ヨーロッパ
      • アジア太平洋
      • 南アメリカ
      • 中央アメリカ
      このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいて、先天性心疾患治療市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、中南米。各地域ごとの先天性心疾患治療市場は、その後、それぞれの国とセグメントごとにサブセグメント化されます。このレポートは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会をカバーしています。レポートは、需要と供給の両方の側面から先天性心疾患治療市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場ダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、中南米では、これらの地域の先天性心疾患治療市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。 市場関係者 レポートは、有機的および無機的な成長戦略として、先天性心疾患治療市場、肛門がん市場の主要な発展をカバーしています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。世界市場での先天性心疾患治療の需要の高まりに伴い、先天性心疾患治療市場の市場プレーヤーは、将来的に有利な成長の機会があると予想されています。以下は、先天性心疾患治療市場に従事する数社のリストです。レポートには、先天性心疾患治療市場の主要企業のプロフィールとSWOT分析および市場戦略も含まれています。さらに、このレポートは、企業概要、過去 3 年間の財務情報、過去 5 年間の主要な開発などの情報を提供する業界の主要企業に焦点を当てています。
        • Novartis AG • Merck and Co. Inc. • Pfizer Inc. • Amgen Inc. • Abbott Laboratories • Sanofi SA • GlaxoSmithKline plc • Eli Lilly および会社名 • AstraZeneca plc • Medtronic plc
      Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供しています。

      Congenital Heart Disease Treatment Market Report Scope

      Report Attribute Details
      Market size in US$ XX million
      Market Size by US$ XX Million
      Global CAGR XX%
      Historical Data 2021-2022
      Forecast period 2024-2031
      Segments Covered By タイプ(薬物療法,外科療法)
      By エンドユーザー(病院,診療所,診断センター)
      By 地理
      • 北アメリカ
      • ヨーロッパ
      • アジア太平洋
      • 南アメリカ
      • 中央アメリカ
      Regions and Countries Covered 北米(米国,カナダ,メキシコ)
      • 北米(米国
      • カナダ
      • メキシコ)
      ヨーロッパ(英国,ドイツ,フランス,ロシア,イタリア,その他のヨーロッパ)
      • ヨーロッパ(英国
      • ドイツ
      • フランス
      • ロシア
      • イタリア
      • その他のヨーロッパ)
      アジア太平洋(中国,インド,日本,オーストラリア,その他のアジア太平洋)
      • アジア太平洋(中国
      • インド
      • 日本
      • オーストラリア
      • その他のアジア太平洋)
      南米および中米(ブラジル,アルゼンチン,その他の中南米)
      • 南米および中米(ブラジル
      • アルゼンチン
      • その他の中南米)
      中東およびアフリカ(南アフリカ,サウジアラビア,UAE,その他の中東およびアフリカ)
      • 中東およびアフリカ(南アフリカ
      • サウジアラビア
      • UAE
      • その他の中東およびアフリカ)
      Market leaders and key company profiles
    • Novartis AG
    • Merck and Co Inc
    • Pfizer Inc
    • Amgen Inc
    • Abbott Laboratories
    • Sanofi S A
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • AstraZeneca plc
    • Report Coverage
      Report Coverage

      Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

      Segment Covered
      Segment Covered

      This text is related
      to segments covered.

      Regional Scope
      Regional Scope

      North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

      Country Scope
      Country Scope

      This text is related
      to country scope.

      1. Novartis AG
      2. Merck and Co. Inc.
      3. Pfizer Inc.
      4. Amgen Inc.
      5. Abbott Laboratories
      6. Sanofi S.A.
      7. GlaxoSmithKline plc
      8. Eli Lilly and Company
      9. AstraZeneca plc
      10. Medtronic plc

      The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

      1. Data Collection and Secondary Research:

      As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

      Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

      1. Primary Research:

      The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

      For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

      A typical research interview fulfils the following functions:

      • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
      • Validates and strengthens in-house secondary research findings
      • Develops the analysis team’s expertise and market understanding

      Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

      • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
      • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

      Below is the breakup of our primary respondents by company, designation, and region:

      Research Methodology

      Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

      1. Data Analysis:

      Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

      • Macro-Economic Factor Analysis:

      We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

      • Country Level Data:

      Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

      • Company Profile:

      The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

      • Developing Base Number:

      Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

      1. Data Triangulation and Final Review:

      The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

      We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

      We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

      Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

      Trends and growth analysis reports related to Pharmaceuticals : READ MORE..